Novo Nordisk | NVO - 借入資本

株価
36.83
毎日の変更
-0.20 -0.54%
毎月
-7.07%
毎年
-52.07%
Q1 予測
34.66




借入資本 変化する 日付
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Aurora Cannabis CAD 33.2M 1.79M 2025-12
Bausch Health Companies USD 20.62B 152M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 224.99M 1.34M 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Merck USD 39.97B 6B 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Novartis USD 29.59B 5.35B 2025-12
Novo Nordisk DKK 118.94B 29.76B 2025-12
Novo Nordisk DKK 14.02B 224.49M 2025-09
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Zoetis USD 9.04B 1.97B 2025-12